IRIS Accounts Production v24.3.2.46 04174268 director 1.4.23 31.3.24 31.3.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh041742682023-03-31041742682024-03-31041742682023-04-012024-03-31041742682022-03-31041742682022-04-012023-03-31041742682023-03-3104174268ns15:EnglandWales2023-04-012024-03-3104174268ns14:PoundSterling2023-04-012024-03-3104174268ns10:Director12023-04-012024-03-3104174268ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3104174268ns10:SmallEntities2023-04-012024-03-3104174268ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3104174268ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3104174268ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3104174268ns10:FullAccounts2023-04-012024-03-3104174268ns10:RegisteredOffice2023-04-012024-03-3104174268ns5:CurrentFinancialInstruments2024-03-3104174268ns5:CurrentFinancialInstruments2023-03-3104174268ns5:Non-currentFinancialInstruments2024-03-3104174268ns5:Non-currentFinancialInstruments2023-03-3104174268ns5:ShareCapital2024-03-3104174268ns5:ShareCapital2023-03-3104174268ns5:RetainedEarningsAccumulatedLosses2024-03-3104174268ns5:RetainedEarningsAccumulatedLosses2023-03-3104174268ns5:PlantMachinery2023-04-012024-03-3104174268ns5:PlantMachinery2023-03-3104174268ns5:PlantMachinery2024-03-3104174268ns5:PlantMachinery2023-03-3104174268ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3104174268ns5:WithinOneYearns5:CurrentFinancialInstruments2023-03-3104174268ns5:DeferredTaxation2023-03-3104174268ns5:DeferredTaxation2023-04-012024-03-3104174268ns5:DeferredTaxation2024-03-31041742681ns10:Director12023-03-31041742681ns10:Director12022-03-31041742681ns10:Director12023-04-012024-03-31041742681ns10:Director12022-04-012023-03-31041742681ns10:Director12024-03-31041742681ns10:Director12023-03-31
REGISTERED NUMBER: 04174268 (England and Wales)









FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

FOR

VITAL PHASE UK LIMITED

VITAL PHASE UK LIMITED (REGISTERED NUMBER: 04174268)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


VITAL PHASE UK LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2024







DIRECTOR: P Vella





REGISTERED OFFICE: 4th Floor Tuition House
27/37 St George's Road
Wimbledon
London
SW19 4EU





REGISTERED NUMBER: 04174268 (England and Wales)





ACCOUNTANTS: Hartley Fowler LLP
Chartered Accountants
4th Floor Tuition House
27-37 St George's Road
Wimbledon
London
SW19 4EU

VITAL PHASE UK LIMITED (REGISTERED NUMBER: 04174268)

BALANCE SHEET
31 MARCH 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 12,620 15,767

CURRENT ASSETS
Debtors 5 18,770 21,996
Cash at bank 74,966 87,467
93,736 109,463
CREDITORS
Amounts falling due within one year 6 19,858 20,095
NET CURRENT ASSETS 73,878 89,368
TOTAL ASSETS LESS CURRENT LIABILITIES 86,498 105,135

CREDITORS
Amounts falling due after more than one year 7 (6,667 ) (10,667 )

PROVISIONS FOR LIABILITIES 8 (2,409 ) (3,942 )
NET ASSETS 77,422 90,526

CAPITAL AND RESERVES
Called up share capital 1,000 1,000
Retained earnings 76,422 89,526
SHAREHOLDERS' FUNDS 77,422 90,526

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 7 March 2025 and were signed by:





P Vella - Director


VITAL PHASE UK LIMITED (REGISTERED NUMBER: 04174268)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024


1. STATUTORY INFORMATION

Vital Phase UK Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Significant judgements and estimates
There are no significant accounting judgements and estimates that require disclosure.

Turnover
Turnover, which excludes VAT, represents amounts chargeable for services provided to third parties in the normal course of business. Revenue from services is measured at fair value and recognised when the service is provided and the right to consideration earned. To the extent that a service is provided to third parties but no billing made, the amount is recognised as revenue and recorded as accrued income. Billings made in advance of services being provided are recognised as deferred income.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33% on reducing balance

Financial instruments
Cash at bank is measured at transaction price.

Debtors and creditors with no stated interest rate and receivables or payables within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other
administrative expenses.

Dividends
Dividends are recognised in the company's financial statements in the year in which they are approved in general meetings by the company's shareholders. Interim dividends are recognised when they are paid.

Share capital
Ordinary shares are classified as equity.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


VITAL PHASE UK LIMITED (REGISTERED NUMBER: 04174268)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Impairments
Assets not measured at fair value are reviewed for any indication that the asset may be impaired at each balance sheet date. If such indication exists, the recoverable amount of the asset, or the asset's cash generating unit, is estimated and compared to the carrying amount. Where the carrying amount exceeds its recoverable amount, an impairment loss is recognised in profit or loss unless the asset is carried at a revalued amount where the impairment loss is a revaluation decrease.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 April 2023 35,337
Additions 2,299
At 31 March 2024 37,636
DEPRECIATION
At 1 April 2023 19,570
Charge for year 5,446
At 31 March 2024 25,016
NET BOOK VALUE
At 31 March 2024 12,620
At 31 March 2023 15,767

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors - 120
Other debtors 18,770 21,876
18,770 21,996

VITAL PHASE UK LIMITED (REGISTERED NUMBER: 04174268)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024


6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts 4,000 4,000
Taxation and social security 188 154
Other creditors 15,670 15,941
19,858 20,095

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2024 2023
£    £   
Bank loans 6,667 10,667

8. PROVISIONS FOR LIABILITIES
2024 2023
£    £   
Deferred tax 2,409 3,942

Deferred
tax
£   
Balance at 1 April 2023 3,942
Provided during year (1,533 )
Balance at 31 March 2024 2,409

9. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 March 2024 and 31 March 2023:

2024 2023
£    £   
P Vella
Balance outstanding at start of year (14,740 ) (5,357 )
Amounts advanced 1,300 1,713
Amounts repaid - (11,096 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (13,440 ) (14,740 )

The balance is unsecured, non-interest bearing and has no repayment terms.

10. ULTIMATE CONTROLLING PARTY

The company is controlled by P Vella, the director and sole shareholder.